Lemonade (LMND) has drawn investor attention after its recent share performance, with the stock down about 9% on the day and softer over the past week, month, and past 3 months.

Against that backdrop, Lemonade’s recent share price pressure sits alongside a weaker year to date share price return of about 30%, even as its 1 year total shareholder return of roughly 47% hints at earlier optimism that has cooled.

If you want to see what else is moving in insurance and related financials, it is a good time to scan opportunities in 20 top founder-led companies

With Lemonade stock under pressure despite a roughly 47% 1 year total return and annual revenue growth of about 24%, the key question is whether current prices underappreciate its potential or if markets are already pricing in future growth.

Most Popular Narrative: 19.1% Undervalued

At a last close of $52.66 versus a narrative fair value of $65.11, the current pricing sits below what the most followed narrative implies.

The analysts have a consensus price target of $65.11 for Lemonade based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $98.0, and the most bearish reporting a price target of just $33.0.

The fair value story here leans heavily on rapid revenue expansion, a sharp swing toward profitability, and a rich future earnings multiple that few insurers carry today.

Result: Fair Value of $65.11 (UNDERVALUED)

However, this undervaluation story can quickly weaken if customer acquisition costs stay high or if rising claim volatility pressures margins and delays profitability milestones.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Another View: Multiples Paint a Richer Price Picture

That 19.1% “undervalued” narrative sits awkwardly next to the current sales based view. Lemonade trades on a P/S of 4.8x, compared with 1.1x for both the US Insurance industry and its peers, and a fair ratio of 1.4x, which points to valuation risk rather than a clear bargain.

For investors weighing those gaps against the growth story, it raises a simple question: is this a case of paying up early, or is the market already stretching expectations too far, given the company is still loss making and reliant on future execution to justify the premium multiples?

Next Steps

With sentiment clearly split, it helps to look at the same numbers yourself and decide whether the current setup feels attractive or stretched. To see exactly what optimists are focusing on, review the 2 key rewards

Looking for more investment ideas?

If Lemonade has your attention, do not stop here. Broaden your watchlist now so you are not chasing opportunities after they are already crowded.

• Spot potential value candidates early by scanning 47 high quality undervalued stocks that pair solid fundamentals with prices that may not fully reflect their strengths.
• Build a watchlist with staying power by checking solid balance sheet and fundamentals stocks screener (47 results) that prioritise financial strength and resilience.
• Get ahead of the crowd by searching screener containing 22 high quality undiscovered gems that have quality metrics yet are still off most investors’ radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.